Opthea Limited Overview
Valuation check: OPT's ROE is 236.09%, above the Healthcare sector average of -75.59%.
Get informed when a big investor buys or sells
+ Follow236.09%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for OPT is 236.09%. That is above the Healthcare sector average of -75.59%. Investors often review this figure alongside Opthea Limited's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, OPT currently prints 236.09% for ROE, while the sector average sits near -75.59%. That is roughly 412.3% above the sector mean. Large gaps often invite a closer look at Opthea Limited's growth, margins, and balance sheet.
Return on Equity shows how effectively Opthea Limited converts resources into returns. At 236.09%, OPT may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting OPT's ROE (236.09%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Opthea Limited's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
